Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?
RSPH offers 60 diversified holdings with lower volatility, while BBH concentrates on 25 biotech leaders with stronger recent returns.
Overview
Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) offers equal-weighted exposure to the broad healthcare sector, whereas VanEck Biotech ETF (NASDAQ:BBH) concentrates heavily on the 25 largest biotechnology companies.
Investors may choose among these funds based on their preference for industry-specific concentration or diversified exposure to healthcare. While RSPH targets a wider range of medical services and products with a balanced weighting, BBH focuses strictly on the biotechnology industry using a market-cap-weighted model.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield as of the July 10 close.
Source
Originally published at www.fool.com.